Antinociceptive Activity of Flavonoid-Rich Ethylacetate Fraction of Ocimum gratissimum L. Leaves in Mice
doi.org/10.26538/tjnpr/v5i6.18
Keywords:
Antinociceptive, Ocimum gratissimum, Ethylacetate, FlavonoidAbstract
Ocimum gratissimum L. in an economic plant of immense ethnomedicinal properties. This study evaluated the anti-nociceptive activity of the sequential extracts and flavonoid-rich ethylacetate fraction of O. gratissimum (EAFOg) in mice. The sequential extracts of the dried leaves in hexane, chloroform and methanol and the ethylacetate fraction were assessed in acetic acid-induced writhing and formalin test in mice. Further antinociceptive activity of the ethylacetate fraction (25, 50 and 100 mg/kg) was investigated in hot plate, acetic acid and formalin tests. The results revealed that antinociceptive activity was in the order of ethylacetate > methanol > chloroform > hexane. EAFOg demonstrated activity in the hot plate, acetic acid and formalin test, respectively. The antinociceptive activity of EAFOg (100 mg/kg) was not reversed by pre-treatment with the opioid antagonist (Naloxone, 1 mg/kg, i.p) when assessed in the hot plate test. Furthermore, the antinociceptive effect of EAFOg (100 mg/kg) was reversed by L-NAME (10mg/kg) and yohimbine (2 mg/kg) but not atropine (2 mg/kg) when assessed in the acetic acid-induced writhing test. This suggests an interaction with the nitric oxide and adrenergic pathway. The results suggest that the flavonoid-rich ethylacetate fraction of O. gratissimum (EAFOg) may have beneficial effect against neurogenic and inflammatory pain.
References
Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. AJTCAM. 2013; 10(5):210-229.
Smith-Hall C, Larsen HO, Pouliot M. People, plants and health: a conceptual framework for assessing changes in medicinal plant consumption. J Ethnobiol Ethnomed. 2012; 8(1):43.
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacol. 2014; 4:177.
Newman DJ and Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012; 23:311-335.
Karimi A, Majlesi M, Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol.2015; 4(1):27.
Gupta LM and Raina R. Side effects of some medicinal plants. Current Sci. 1998; 75(9):897-900.
Mahdi JG. Medicinal potential of willow: A chemical perspective of aspirin discovery. J Saudi Chem Soc. 2010;14(3):317-322.
Orafidiya LO, Agbani EO, Iwalewa EO, Adelusola KA, Oyedapo OO. Studies on the acute and sub-chronic toxicity of the essential oil of Ocimum gratissimum L. leaf. Phytomed. 2004; 11(1):71-76
Iwu MM. Handbook of African Medicinal Plants. CRC Press, Boca Raton, Florida 1993. 183-184 p.
Onajobi FD. Smooth Muscle contracting lipid-soluble principles in chromatographic fractions of Ocimum gratissimum. J Ethnopharmacol. 1986; 18(1):3-11.
Orafidiya OO, Elujoba AA, Iwalewa EO and Okeke IN. Evaluation of anti-diarrhoeal properties of Ocimum gratissimum volatile oils and its activity against enteroaggregative Escherichia coli. Pharm Pharmacol Lett. 2000; 10:9-12.
Faria TDJ, Ferreira RS, Yassumoto L, Souza JRPD, Ishikawa NK, Barbosa ADM. Antifungal activity of essential oil isolated from Ocimum gratissimum L.(eugenol chemotype) against phytopathogenic fungi. Braz Arch BiolTech. 2006; 49(6):867-871.
Rabelo M, Souza EP, Soares PMG, Miranda AV, Matos FJA, Criddle DN. Antinociceptive properties of the essential oil of Ocimum gratissimum L.(Labiatae) in mice. Braz J Med Bio Res. 2003; 36(4):521-524.
Paula-Freire LIG, Andersen ML, Molska GR, Köhn DO, Carlini ELA. Evaluation of the Antinociceptive Activity of Ocimum gratissimum L. (Lamiaceae) Essential Oil and its isolated Active Principles in Mice. Phytother Res. 2013; 27: 1220-1224
Ajayi AM, Tanayen JK, Ezeonwumelu JOC, Dare S, Okwanachi A, Adzu B, Ademowo OG. Anti-inflammatory, anti-nociceptive and total polyphenolic content of hydroethanolic extract of Ocimum gratissimum L. leaves. Afr J Med Med Sci. 2014; 43(Suppl 1): 215-224.
Altemimi A, Lakhssassi N, Baharlouei A, Watson D, Lightfoot D. Phytochemicals: Extraction, isolation, and identification of bioactive compounds from plant extracts. Plants 2017; 6(4):42.
Ajayi AM, Ologe MO, Ben-Azu B, Okhale SE, Adzu B, Ademowo OG. Ocimum gratissimum Linn. Leaf extract inhibits free radical generation and suppressed inflammation in carrageenan-induced inflammation models in rats. J Basic Clin Physiol Pharmacol. 2017a; 28(6):531-541.
Ajayi AM, de Oliveira Martins DT, Balogun SO, de Oliveira RG, Ascêncio SD, Soares IM, Ademowo OG. Ocimum gratissimum L. leaf flavonoid-rich fraction suppress LPS-induced inflammatory response in RAW 264.7 macrophages and peritonitis in mice. J Ethnopharmacol. 2017b; 204:169-178.
Koster R, Anderson M, DeBeer EJ. Acetic acid for analgesic screening. Fed Pro. 1959; 18:412.
Hunskaar S and Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 1987; 30(1):103-114.
Dubuisson D and Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain1977; 4:161-174.
Eddv NB and Leimbach D. Svnthesis analgesics. II. Dithienylbutenyl and dithienylbhtylamides. J Pharmacol Exp Therap. 1953; 107:385-393.
Parcha V, Dobhal Y, Dhasmana DC. Isolation, characterization and cardioprotective potential of gratissinol from chloroform extract of Ocimum gratissimum (Linn.) Leaves. J Bio Active Products from Nat. 2019; 9(4):260-268.
Bansal A, Chhabra V, Rawal RK, Sharma S.Chemometrics: A new scenario in herbal drug standardization. J Pharm Anal. 2014; 4(4):223-233.
Deraedt R, Jouquey S, Delevallée F, Flahaut M. Release of prostaglandins E and F in an algogenic reaction and its inhibition. Euro J Pharmacol. 1980; 61(1):17-24.
Bentley GA, Newton SH, Starr J. Studies on the antinociceptive action of α‐agonist drugs and their interactions with opioid mechanisms. Br J Pharmacol. 1983;79(1):125-134.
Abbott FV, Franklin KB, Westbrook RF. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 1995; 60(1):91-102.
Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992; 51(1):5-17.
Lee IO and Jeong YS. Effects of different concentrations of formalin on paw edema and pain behaviors in rats. J Korean Med Sci. 2002; 17(1):81.
Duarte ID, Nakamura M, Ferreira SH. Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res. 1988; 21(2):341-343.
Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Clin Invest. 2010; 120(11):3779-3787.
Ma D, Rajakumaraswamy N, Maze M. α2-Adrenoceptor agonists: shedding light on neuroprotection. Br Med Bull. 2005; 71(1):77-92.
Rahim A, Hafiz M, Zakaria ZA, Sani M, Hijaz M, Omar MH, Abdul Kadir A. Methanolic extract of Clinacanthus nutans exerts antinociceptive activity via the opioid/nitric oxide-mediated, but cGMP-independent, pathways. EvidBased Compl Altern Med. 2016
Abacıoğlu N, Tunçtan, B, Akbulut E, Çakıcı İ. Participation of the components of L-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouse. Life Sci. 2000; 67(10):1127-1137.
Cai YQ, Chen SR, Han HD, Sood AK, Lopez‐Berestein G, Pan HL. Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats. J Neurochem. 2009;111(4):1000-1010.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
